MDM2 GENE AMPLIFICATION IN HUMAN BREAST-CANCER

被引:62
作者
QUESNEL, B
PREUDHOMME, C
FOURNIER, J
FENAUX, P
PEYRAT, JP
机构
[1] CTR OSCAR LAMBRET,F-59020 LILLE,FRANCE
[2] CHU LILLE,SERV MALAD SANG,F-59037 LILLE,FRANCE
[3] CHU LILLE,INST RECH CANC,INSERM,U124,F-59037 LILLE,FRANCE
[4] CHU LILLE,HEMATOL LAB,F-59037 LILLE,FRANCE
关键词
MDM2; GENE AMPLIFICATION; BREAST CANCER; ESTRADIOL RECEPTOR;
D O I
10.1016/0959-8049(94)90128-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The MDM2 gene is a gene whose product binds to p53 and regulates its functions. The amplification of the MDM2 gene has been found in one third of human sarcomas, and a differential expression of MDM2 gene in relation with oestrogen receptor status was recently found in human breast cancer cell lines. We analysed 60 breast cancers for MDM2 gene amplification by Southern blot. This event was observed in 1 case with high levels of oestrogen receptor (ER). Thus, MDM2 gene amplification seems to be a rare event in breast cancer. Further studies are needed to define precisely the relationship between MDM2 amplification and ER status.
引用
收藏
页码:982 / 984
页数:3
相关论文
共 16 条
[1]   PROGNOSTIC-SIGNIFICANCE OF TP53 ALTERATIONS IN BREAST-CARCINOMA [J].
ANDERSEN, TI ;
HOLM, R ;
NESLAND, JM ;
HEIMDAL, KR ;
OTTESTAD, L ;
BORRESEN, AL .
BRITISH JOURNAL OF CANCER, 1993, 68 (03) :540-548
[2]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[3]  
BONNETERRE J, 1990, CANCER RES, V50, P6931
[4]   MUTATIONS IN HUMAN-BREAST CANCER - AN OVERVIEW [J].
CALLAHAN, R ;
CAMPBELL, G .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (23) :1780-1786
[5]   TUMORIGENIC POTENTIAL ASSOCIATED WITH ENHANCED EXPRESSION OF A GENE THAT IS AMPLIFIED IN A MOUSE-TUMOR CELL-LINE [J].
FAKHARZADEH, SS ;
TRUSKO, SP ;
GEORGE, DL .
EMBO JOURNAL, 1991, 10 (06) :1565-1569
[6]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[7]  
KHATIB ZA, 1993, CANCER RES, V53, P5535
[8]   STANDARDIZATION OF STEROID-RECEPTOR ASSAYS IN HUMAN-BREAST CANCER .4. LONG-TERM WITHIN-LABORATORY AND BETWEEN-LABORATORY VARIATION OF ESTROGEN AND PROGESTERONE-RECEPTOR ASSAYS [J].
KOENDERS, A ;
THORPE, SM .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (08) :945-952
[9]  
LADANYI M, 1993, CANCER RES, V53, P16
[10]  
MANIATIS T, 1990, MOL CLONING